Charles River Laboratories | CRL - درآمد حاصل از بهره

قیمت سهام
170.05
تغییر روزانه
2.31 1.38%
ماهیانه
6.82%
سالیانه
46.90%
Q2 پیش بینی
179.83




درآمد حاصل از بهره تغییر دادن تاریخ
Agilent USD 17M 1000K 2025-09
Align Technology USD 3.25M 390K 2025-09
Bio-Rad Laboratories USD 13.7M 1000K 2025-09
Bruker USD 4.4M 1.5M 2025-09
Charles River Laboratories USD 1.1 1.1M 2025-09
Concord Medical Services Hldg CNY 5.8M 659K 2023-06
Danaher USD 27M 14M 2026-03
Dentsply International USD 4M 1000K 2025-03
Galapagos EUR 12.56M 4.66M 2025-03
Illumina USD 0.98 10M 2025-09
Incyte USD 30.75M 3.97M 2025-12
Intrexon USD 319K 602K 2024-06
IQVIA Holdings USD 11M 2M 2025-12
Merck EUR 27M 10M 2025-09
Pfizer USD 0.62 156M 2025-09
Quest Diagnostics USD 3M 0 2025-12
Revvity USD 0.4 8.34M 2025-09
Thermo Fisher Scientific USD 258M 258M 2025-12
United Therapeutics USD 46.4M 4.9M 2025-09
Veradigm USD 1.7M 1.6M 2022-09
Waters USD 2.5 4.51M 2025-09
West Pharmaceutical Services USD 5.1M 400K 2025-12